FDA Panel Favors Cymbalta Expansion – Yahoo Finance

Eli Lilly is seeking approval for the use of Cymbalta for the management of chronic low back pain and treatment of chronic pain due to osteoarthritis. The advisory panel was also asked to vote on whether sufficient data …

Read the original here:
FDA Panel Favors Cymbalta Expansion – Yahoo Finance